Emcure Pharmaceuticals Ltd Quarterly Results

Gross Sales

2,116.25

1,962.63

2,001.98

1,815.14

1,771.36

Excise Duty

0

0

0

0

0

Net Sales

2,116.25

1,962.63

2,001.98

1,815.14

1,771.36

Other Operating Income

0

0

0

0

0

Other Income

4.45

-3.24

35.65

23.44

11.74

Total Income

2,120.7

1,959.39

2,037.64

1,838.58

1,783.1

Total Expenditure

1,724.22

1,600.89

1,621.11

1,478.82

1,460.14

PBIDT

396.48

358.5

416.53

359.76

322.95

Interest

39.03

31.78

46.22

58.76

65.49

PBDT

357.45

326.73

370.31

301

257.47

Depreciation

96.84

96.81

96.9

93.59

90.56

Minority Interest Before NP

0

0

0

0

0

Tax

91.55

58.93

79.8

61.87

28.69

Deferred Tax

-28.18

14.9

-7.94

-7.05

17.2

Reported Profit After Tax

197.24

156.09

201.55

152.59

121.02

Minority Interest After NP

8.28

2.37

6.98

8.51

5.85

Net Profit after Minority Interest

188.96

153.72

194.57

144.08

115.17

Extra-ordinary Items

-6.73

0

0

0

-0.1

Adjusted Profit After Extra-ordinary item

195.69

153.72

194.57

144.08

115.27

EPS (Unit Curr.)

9.97

8.12

10.23

7.95

6.36

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

30

0

0

0

0

Equity

189.48

189.43

189.1

181.15

181.15

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

18.73

18.26

20.8

19.81

18.23

PBDTM(%)

16.89

16.64

18.49

16.58

14.53

PATM(%)

9.32

7.95

10.06

8.4

6.83